Acceptance and Commitment Therapy for Bipolar Disorder

ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder

Recruiting N/A Interventional Study
Bipolar Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
42 (estimated)
Sponsor
Beny Lafer · Other
Who this trial is looking for

This trial is looking for people with Bipolar Disorder who have depressive symptoms. Participants will receive therapy sessions designed to improve their mood and quality of life while they continue their regular medication.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with Bipolar Disorder type I or II.
  • I have depressive symptoms.
  • I am not currently undergoing psychotherapy.
  • I can attend in-person group therapy sessions.
  • I am willing to sign a consent form.

You may not be able to join if

  • I have an organic mental disorder.
  • I have manic or hypomanic symptoms.
  • I am currently undergoing psychotherapy.
  • I have had a major medication change in the last 30 days.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to test the efficacy of Acceptance and Commitment Therapy (ACT) as a psychotherapeutic treatment for patients with Bipolar Disorder (BD). The following questions will be investigated: * The efficacy of ACT in reducing depressive symptoms in patients with BD. * The efficacy of ACT in improving the quality of life in patients with BD. * The efficacy of ACT in impr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of Bipolar Disorder type I and II according to DSM V * Presence of depressive symptoms (MADRS\>12) * Not undergoing psychotherapy * Availability to attend in-person group therapy sessions * Signing consent form Exclusion Criteria: * Organic mental disorder * Presen…
Contacts

Beny Lafer, MD PhD

+5511 999381849

Benylafer@gmail.com

CONTACT

Tatiana C Khafif, Master's degree

+5511 98338-9643

tatianakhafif@usp.br

CONTACT